Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 11/18/21
End: 02/07/24
Due: 02/07/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Validation of Drug Assays in Various Biological Matrices | NCT02283112 | Helen Reynolds | user2@example.com | None | 2014-10-31 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| The Effect of Antacids and Multivitamins on Raltegravir | NCT01784302 | Helen Reynolds | user2@example.com | None | 2014-04-30 | 2016-02-29 | 2017-02-28 | - | - | 2025-07-14 |
| The Effect of Intermittent Rifampicin on Raltegravir | NCT01424826 | Helen Reynolds | user2@example.com | None | 2012-01-31 | 2013-07-31 | 2014-07-31 | - | - | 2025-07-14 |
| Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin | NCT04166474 | Helen Reynolds | user2@example.com | None | 2021-11-18 | 2024-02-07 | 2025-02-07 | - | - | 2025-07-14 |